Ignite Creation Date:
2025-12-24 @ 6:36 PM
Ignite Modification Date:
2026-01-02 @ 12:58 AM
Study NCT ID:
NCT05354557
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-05-18
First Post:
2022-04-26
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of Iberdomide in People With Multiple Myeloma Who Have Had an Autologous Hematopoietic Stem Cell Transplant (AHCT)
Sponsor:
Memorial Sloan Kettering Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-04-26
Start Date Type:
ACTUAL
Primary Completion Date:
2026-04-26
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-04-26
Completion Date Type:
ESTIMATED
First Submit Date:
2022-04-26
First Submit QC Date:
None
Study First Post Date:
2022-04-29
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-05-14
Last Update Post Date:
2025-05-18
Last Update Post Date Type:
ACTUAL